Silver Oak Securities’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,188
| Closed | -$29.9K | – | 721 |
|
|
2025
Q1 | $29.9K | Buy |
+20,188
| New | +$29.9K | ﹤0.01% | 638 |
|
|
2024
Q1 | – | Sell |
-5,189
| Closed | -$35.7K | – | 537 |
|
|
2023
Q4 | $35.7K | Buy |
+5,189
| New | +$35.7K | ﹤0.01% | 487 |
|
|
2023
Q3 | – | Sell |
-5,189
| Closed | -$43K | – | 491 |
|
|
2023
Q2 | $43K | Hold |
5,189
| – | – | 0.01% | 421 |
|
|
2023
Q1 | $23K | Sell |
5,189
-5
| -0.1% | -$22 | ﹤0.01% | 396 |
|
|
2022
Q4 | $31K | Buy |
+5,194
| New | +$31K | 0.01% | 302 |
|
|
2022
Q3 | – | Sell |
-5,194
| Closed | -$64K | – | 496 |
|
|
2022
Q2 | $64K | Buy |
+5,194
| New | +$64K | 0.01% | 277 |
|